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Summary
Background: Integrin signaling, stimulated by cell adhe-
sion to the extracellular matrix, plays a critical role in co-
ordinating changes in cell morphology and migration.
The requisite remodeling of the cytoskeleton is con-
trolled by the Rho family of small GTPases, which are,
in turn, regulated via activation by guanine-nucleotide
exchange factors (GEFs) and inactivation by GTPase-
activating proteins (GAPs). However, the mechanisms
contributing to the precise spatial and temporal regula-
tion of these Rho GTPase modulators remain poorly
understood.
Results: The Cdc42/Rac GAP CdGAP has previously
been implicated as an inhibitor of growth-factor-in-
duced lamellipodia formation. Herein, CdGAP is shown
to localize to focal adhesions, potentially through its di-
rect association with the amino terminus of actopaxin,
a paxillin and actin binding protein. CdGAP activity is
regulated in an adhesion-dependent manner and,
through the overexpression of wild-type CdGAP and
a GAP-deficient mutant, as well as RNA interference, is
shown to be required for normal cell spreading, polar-
ized lamellipodia formation, and cell migration. Intro-
duction of an actopaxin mutant defective for CdGAP
binding, or reduction of actopaxin by using RNAi, signif-
icantly attenuated these effects.
Conclusions: We have established that CdGAP is an im-
portant regulator of integrin-induced Rho family signal-
ing to the cytoskeleton and that its interaction with the fo-
cal-adhesion protein actopaxin is critical for the correct
spatial and/or temporal regulation of CdGAP function.
A complete understanding of the coordination of signal-
ing events downstream of integrin engagement with the
extracellular matrix will provide valuable insight into the
regulation of cell migration during processes such as
wound repair, development, and tumor cell metastasis.
Introduction
The Rho family of GTPases, including Cdc42, Rac, and
RhoA, are critical regulators of cell morphology, signal
*Correspondence: turnerce@upstate.edutransduction, and motility. As such, their activity impacts
upon multiple physiologic processes, including chemo-
taxis, neurite outgrowth, and embryonic development
[1–3]. Misregulation of their signaling cascades contrib-
utes to cell transformation and disease states such as
the Wiskott-Aldrich and Aarskog syndromes [4, 5].
Many of their effects are achieved through modulation
of the cellular cytoskeleton as a result of binding to,
and subsequent activation of, downstream effectors
such as the p21-activated kinase (PAK), the Wiskott-Al-
drich syndrome protein (WASP) and Diaphanous-related
formins [6]. The GTPases themselves are positively reg-
ulated by guanine nucleotide exchange factors (GEFs)
that catalyze the exchange of GDP for GTP and nega-
tively regulated by GTPase-activating proteins (GAPs)
that stimulate the hydrolysis of GTP back to GDP. The lo-
calized activation of the individual Rho GTPases in time
and space has been well documented, for instance fol-
lowing growth-factor stimulation, integrin activation dur-
ing cell spreading, lamellipodia formation, or directed
motility [7–9]. However, establishing which of the 69
GEFs and 80 potential Rho GAPs are utilized in response
to a given stimulus and how they are themselves locally
recruited and regulated requires further study [10, 11].
One emerging mechanism by which cells may recruit
and regulate the localized activity of GEFs and GAPs is
through the utilization of scaffold or adaptor proteins
that are enriched in focal complexes and adhesions
[12]. Focal complexes/adhesions are macromolecular
structures that are assembled at sites of integrin en-
gagement with the extracellular matrix and serve as
both a structural link to the actin cytoskeleton, neces-
sary for traction during cell migration, and as signal
transduction centers. Paxillin is one of the prototypical
focal-adhesion scaffold proteins and contributes to the
localized regulation of Rho family GTPase signaling at
focal adhesions through the recruitment of the Cdc42
and Rac GEF PIX via interaction with the Arf GAPs
GIT1 and GIT2 (PKL) [13]. These Arf GAPs also indirectly
terminate Rac activity through inhibition of Arf6 [14].
Paxillin, when tyrosine phosphorylated, as occurs after
integrin ligation, may also recruit the atypical Rac GEF
DOCK180/ELMO/Crk complex to stimulate integrin-
dependent Rac activation [15].
Interestingly, another paxillin binding partner and
scaffold protein, actopaxin (a-parvin), is emerging as
a bipartite regulator of GTPase activity. Initial studies in-
dicated that actopaxin recruitment to focal adhesions,
via its interaction with paxillin, was necessary for normal
cell spreading [16]. Subsequently, phosphorylation of
the actopaxin amino terminus was shown to stimulate
lamellipodia formation, an indication of elevated Rac
signaling [17]. This phenotype can, in part, be explained
by the ability of actopaxin and another parvin family
member, affixin (b-parvin), to interact with PIX ([18] and
our unpublished observations). In addition, in this report
we show that actopaxin further regulates the dynamic
activity of Rho GTPases through the recruitment to focal
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1376Figure 1. CdGAP Localizes to Focal Adhe-
sions
(A) U2OS osteosarcoma cells were cotrans-
fected with GFP-CdGAP and RFP-actin.
GFP-CdGAP was imaged in live cells by using
Total Internal Reflection Fluorescence (TIRF)
microscopy, whereas the RFP-actin image
was obtained by using epifluorescence.
CdGAP localizes to the ends of F-actin-con-
taining stress fibers. Scale bar represents
10 mm.
(B) Further examples of cells imaged as in (A).
Merged images represent GFP-CdGAP
(green) and RFP-actin (red) in U2OS cells.
(C) U2OS cells were cotransfected with GFP-
CdGAP and DsRed-paxillin and processed
for microscopy as above. CdGAP is shown
to localize to focal adhesions.adhesions of the Cdc42- and Rac-specific GAP CdGAP.
Furthermore, we show that this GAP, which was previ-
ously reported to regulate growth-factor-induced lamel-
lipodia formation [19], also plays a significant role in
integrin-dependent signaling to the cytoskeleton to reg-
ulate cell spreading and cell migration.
Results and Discussion
CdGAP Localizes to Focal Adhesions
Integrins perform an important role in regulating the ac-
tivation of Rho GTPases [20, 21]. This suggests that the
key GTPase regulatory proteins (i.e., GEFs and GAPs)
may be localized and activated at sites of integrin liga-
tion with the extracellular matrix (ECM). Indeed, the
GEFs aPIX and bPIX and GAPs p122RhoGAP and RC-
GAP72 have been reported to localize to focal adhe-
sions [22–24]. Although CdGAP, a GAP for Rac and
Cdc42, is enriched in ruffles after growth-factorstimulation, its distribution in spreading cells has not
been evaluated [25]. Thus, we examined the subcellular
localization of CdGAP in spreading U2OS osteosarcoma
cells plated on collagen in the presence of serum. Live
cells, cotransfected with GFP-CdGAP and RFP-actin,
were imaged with total internal reflection fluorescence
(TIRF) microscopy, and CdGAP was found to be con-
centrated at the ends of actin stress fibers (Figures 1A
and 1B). TIRF imaging provided clear localization of
CdGAP to adhesions sites, whereas epifluorescence im-
aging of these same cells showed less distinct localiza-
tion because of a sizable pool of cytoplasmic CdGAP
(data not shown). In addition, GFP-CdGAP was cotrans-
fected with DsRed-paxillin, and TIRF microscopy imag-
ing of these cells confirmed that a pool of CdGAP is en-
riched with paxillin at focal adhesions (Figure 1C). GFP
expressed as a control did not show an enrichment at fo-
cal-adhesion structures, indicating the specificity of the
CdGAP localization (data not shown). The localization of
CdGAP-Actopaxin Interaction in Integrin Signaling
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spreading cells as compared to cells that had been
plated for an extended time period, suggesting the lo-
calization may be dynamically regulated (data not
shown). A similar localization of endogenous CdGAP
was also observed (see Figure S1 in the Supplemental
Data available online).
A Role for CdGAP GTPase Activity in Cell Spreading
and Polarization
For determining whether CdGAP activity was modulated
in response to integrin ligation, GFP-CdGAP-expressing
U2OS osteosarcoma cells were either held in suspen-
sion or spread on collagen for 15, 30, 60, or 150 min,
a process that mimics signaling and morphologic
changes occurring during the formation of lamellipodia
at the leading edge of migrating cells [26]. The CdGAP
was immunoprecipitated from cell lysates, and GAP as-
says were performed with GTP-loaded Rac as a sub-
strate. The GAP activity of CdGAP was found to increase
by up to 40% over the time course of integrin ligation,
with significantly more activity at 60 and 150 min after
adhesion than in suspension (Figure 2A), suggesting
a potential role in limiting lamellipodia extension.
To formally test whether CdGAP is involved in the reg-
ulation of integrin-mediated Rho GTPase signaling, we
first generated a CdGAP mutant (R56AN169V) that, on
the basis of homology with other GAPs, would be pre-
dicted to be GAP deficient [19, 27]. GAP assays were
performed, and, indeed, this mutant exhibited a reduc-
tion in GAP activity of over 70% as compared to wild-
type CdGAP (Figure 2B). Next, GFP, GFP-CdGAP, or
GFP-CdGAP R56AN169V was expressed in U2OS cells
to evaluate a causative role for CdGAP activity during
cell spreading. Cells were placed in suspension for 60
min and replated on collagen I-coated coverslips for
15, 30, 60, and 120 min, then fixed and stained with rho-
damine phalloidin to visualize F actin (Figure 3A illus-
trates cells at 120 min). Quantitation of cell area revealed
that wild-type CdGAP decreased spreading at all time
points examined, whereas the GAP-deficient mutant fa-
cilitated spreading at early time points (Figure 3B). The
increased spreading exhibited by the GFP-CdGAP
R56AN169V-expressing cells indicates a specific role
for CdGAP in integrin-dependent Rac signaling, be-
cause this construct should selectively disrupt pro-
cesses involving only endogenous CdGAP activity,
rather than that of the total cellular Cdc42/Rac GAP pool.
U2OS cells generally develop after their initial spread-
ing a highly polarized crescent-like morphology that is
indicative of their motile phenotype [28]. Interestingly,
expression of wild-type CdGAP inhibited the cell’s tran-
sition into a polarized phenotype at 120 min, as evi-
denced by the reduction in number of cells exhibiting
a single dominant lamellipodia (Figures 3A and 3C). In
contrast, the GAP-deficient GFP-CdGAP R56AN169V
mutant increased the percentage of cells exhibiting mul-
tiple lamellipodia, consistent with the perturbation of lo-
calized, if not total, cellular Rac and Cdc42 activity (Fig-
ures 3A and 3C). Notably, this phenotype is similar to
that observed after perturbation of other focal-adhesion
components that regulate adhesion-dependent Cdc42
and Rac activity. For example, deletion of the LD4 motif
of Paxillin, which is the region involved in bindinga protein complex containing the Cdc42/Rac GEF PIX,
the ArfGAP PKL, and the p21-activated kinase [13], dis-
rupts Rac signaling and leads to multiple lamellipodia in
CHO.K1 fibroblasts [29].
Rac is an important mediator of cell spreading [30].
Therefore, to evaluate whether the impact of CdGAP
on lamellipodia formation was the result of modulation
of Rac activity, we performed GST-PBD pull-down as-
says on spreading cells expressing wild-type CdGAP
or the GAP-deficient mutant. GFP-CdGAP-expressing
cells exhibited a substantial reduction in the level of ac-
tive Rac, whereas, interestingly, CdGAP R56AN169V-
expressing cells had total active Rac levels comparable
to GFP control cells at 30 min after spreading (Fig-
ure 3D). Thus, the elevated spreading and multiple
lamellipodia formation resulting from overexpression
of the GAP-deficient CdGAP are most likely due to
Figure 2. CdGAP’s GAP Activity Is Regulated by Integrin Ligation
(A) U2OS cells transfected with GFP-CdGAP were lysed either in
suspension or at 15, 30, 60, or 150 min after adhesion to 10 mg/ml
collagen. GFP immunoprecipitations were then performed, and the
immune complexes were subjected to in vitro GAP assays with
(g-32P) GTP-loaded Rac as the substrate, with less bound GTP indi-
cating higher GAP activity. The inset blot confirms that equal
amounts of GFP-CdGAP were precipitated for each time point.
The control reaction was performed from cells transfected with
GFP and indicates the baseline hydrolysis of GTP. * indicates a sig-
nificant statistical activation of CdGAP at 60 and 150 min as com-
pared to the activity levels found in suspended cells, p < 0.05. Error
bars represent the standard deviation.
(B) U2OS cells expressing the indicated constructs were lysed, fol-
lowed by GFP immunoprecipitations and in vitro GAP assays.
CdGAP-R56AN169V has a significant reduction of GAP activity as
compared to wild-type CdGAP. Error bars represent standard devi-
ation from four separate experiments. * indicates significantly more
hydrolysis than GFP control, p < 0.001. Expression levels of con-
structs are illustrated by western blotting for GFP.
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(A) U2OS cells transfected with GFP, GFP-CdGAP, or GFP-CdGAP R56AN169V were spread on 10 mg/ml collagen-coated coverslips, fixed at
120 min, and stained for F actin. CdGAP-overexpressing cells display decreased spreading, whereas CdGAP R56AN169V-expressing cells
are well spread and often display multiple protrusions. Scale bar represents 10 mm.
(B) U2OS cells expressing the indicated constructs were spread on 10 mg/ml collagen-coated cover slips for 15, 30, 60, or 120 min and then pro-
cessed for area quantitation. CdGAP overexpression inhibits spreading at all time points tested, whereas the GAP-deficient CdGAP R56AN169V
construct significantly facilitates spreading at 15 and 30 min after adhesion, p < 0.01, as indicated by asterisks. Error bars represent the standard
error of the mean (SEM).
(C) An examination of the number of lamellipodia from cells respread as in (A) shows that CdGAP-overexpressing cells rarely develop a single
dominant lamellipodia. CdGAP R56AN169V-expressing cells often have multiple lamellipodia. Error bars represent the standard deviation.
(D) PBD assays were performed at 30 min after adhesion to determine the active Rac levels of U2OS cells transfected with the indicated con-
structs. CdGAP overexpression inhibits Rac activity, whereas this effect is lost with the GAP-deficient variant, CdGAP R56AN169V.a localized perturbation in Rac signaling and is consis-
tent with the enrichment of CdGAP to focal adhesions.
Furthermore, coexpression of active Rac with CdGAP
was able to completely rescue spreading in these cells,
reinforcing the idea that the spreading effects observed
in Figure 3 are due to CdGAP’s GAP activity, as opposed
to any potential scaffold function (areas at 30 min in
square microns: GFP, 1018; V12 Rac, 1695; CdGAP,
565; and CdGAP/V12 Rac, 1567).
CdGAP RNAi was then performed to evaluate the role
of the endogenous protein in cell spreading. We were
unable to deplete CdGAP expression levels in U2OScells. However, HeLa cells proved to be an effective sys-
tem because CdGAP was significantly depleted from
these cells by up to 90% when either of two oligonucle-
otides to CdGAP was used (Figure 4A). CdGAP deple-
tion increased cell spreading at 30 min after adhesion
on both fibronectin and collagen in these cells (Figures
4B and 4C) (similar effects were seen with both oligos,
data not shown). Identical results were also obtained
with HEK-293 cells (data not shown). Notably, as with
expression of the GAP-deficient construct (Figure 3D),
there was no global increase in Rac activation levels
after CdGAP RNAi (Figure 4D). These data reinforce
CdGAP-Actopaxin Interaction in Integrin Signaling
1379Figure 4. CdGAP Depletion Increases Cell Spreading
(A) Endogenous CdGAP levels were depleted in HeLa cells by using two specific oligonucleotides (Oligo #1 and #2) or a nonspecific oligonucle-
otide as a control. Equivalent total protein is demonstrated by blotting for ILK.
(B) HeLa cells that had received either control oligonucleotide or Oligo #2 were suspended and spread on fibronectin for 30 min and then fixed
and stained for F actin. Cells depleted of CdGAP spread more efficiently. Scale bar represents 10 mm.
(C) HeLa cells were spread on either 10 mg/ml collagen or 10 mg/ml fibronectin and then fixed at 30 min and stained for F actin. Cells depleted of
CdGAP spread more efficiently on both matrices at 30 min. * indicates a significant increase from control cells, p < 0.05. Error bars represent the
SEM.
(D) Control and CdGAP RNAi HeLa cells were evaluated for Rac activity at 30 min after adhesion on fibronectin by using PBD assays.the specific role of CdGAP in cell spreading and local-
ized Rac activation. The results also indicate that
CdGAP’s role in cell spreading is conserved throughout
different cell lines and on different matrices. It is interest-
ing to speculate that localized CdGAP activity both may
serve to facilitate cycling of Rac activity at the cell’s
leading edge, where focal adhesions are also actively
turning over [31], and may function in restricting lateral
membrane extensions during cell polarization and motil-
ity and thereby complement the role of active Rho in this
regard [32].
CdGAP Interacts with Actopaxin
In view of its subcellular distribution, CdGAP was tested
for its ability to bind focal-adhesion proteins, and an in-
teraction with actopaxin was identified. Actopaxin is
a 372 amino acid (aa) F-actin, integrin-linked kinase
and paxillin binding focal-adhesion protein consisting
of an amino-terminal segment containing serine phos-
phorylation sites (aa 1–95), a pair of calponin homology
(CH) domains (aa 96–200 and 262–372), and a hinge re-
gion between the CH domains (aa 201–261) [16]. The as-
sociation between CdGAP and actopaxin was first dem-
onstrated with GST fusion binding assays (Figure 5A).
U2OS cells were transfected with Myc-CdGAP andthen subjected to binding assays with several GST-ac-
topaxin fusion proteins to map the binding site within
actopaxin for CdGAP. Myc-CdGAP was found to inter-
act with full-length (aa 1–372) and amino-terminal seg-
ments (aa 1–95 and aa 1–222) of actopaxin, but not fu-
sion proteins consisting of the actopaxin hinge region
or carboxyl terminus (Figure 5A), thereby mapping the
actopaxin site of interaction with CdGAP to the acto-
paxin amino terminus.
The short (90 kDa) form of CdGAP consists of three
distinct domains, the amino-terminal GAP domain (aa
1–181), the central region (aa 182–515), and the car-
boxy-terminal proline-rich domain (aa 516–820) [25].
Full-length and truncation mutants of CdGAP were ex-
pressed in U2OS cells and tested for their ability to inter-
act with GST-actopaxin. As shown in Figure 5B, GST-ac-
topaxin precipitated CdGAP constructs consisting of
the full-length protein (aa 1–820), the amino-terminal
GAP domain with the central domain (aa 1–515), or the
central domain with the carboxy-terminal proline-rich
domain (aa 182–820) (Figure 5B). However, actopaxin
did not bind the isolated amino-terminal GAP domain
(aa 1–181), the central domain (aa 182–515), or the
carboxy-terminal proline-rich domain (aa 516–820)
(Figure 5B). Therefore, we conclude that actopaxin
Current Biology
1380Figure 5. CdGAP Associates with the Focal-
Adhesion Protein Actopaxin
(A) U2OS cells transfected with Myc-CdGAP
were subjected to binding assays with the in-
dicated GST-actopaxin fusion proteins. Sam-
ples were analyzed via western blotting and
probed for Myc and a-actinin, as a negative
control. Myc-CdGAP was only precipitated
by full-length or amino-terminal pieces of ac-
topaxin.
(B) GST-actopaxin binding assays were per-
formed with cell lysates from U2OS cells
transfected with the indicated CdGAP con-
structs. Actopaxin precipitated full-length
CdGAP (aa 1–820), the full-length GAP-defi-
cient mutant (aa 1–820 R56AN169V), an aa
182–820, or an aa 1–515 construct. Con-
versely, GST-actopaxin does not bind
CdGAP aa 1–181, aa 182–515, or aa 516–
820 constructs.
(C) CdGAP and ILK were synthesized as 35S-
labeled proteins by using an in vitro transcrip-
tion/translation rabbit reticulocyte system
and used in binding assays with GST, GST-
actopaxin 1–372, or GST-actopaxin 1–95. Re-
sults demonstrate that the association be-
tween actopaxin and CdGAP is direct and occurs within the amino-terminal 95 amino acids of actopaxin. ILK was used as a specificity control
because it binds to the actopaxin carboxyl terminus.
(D) Endogenous actopaxin was precipitated from asynchronously growing U2OS cells. The lysate lane contained 20 mg protein, and immunopre-
cipitations were performed from 250 mg each. Endogenous CdGAP coprecipitated with actopaxin, and a-actinin served as a negative control.
The control immunoprecipitation was performed with nonspecific Rabbit IgG. Approximately 10% of available actopaxin was precipitated,
and 1% of endogenous CdGAP was coprecipitated.interacts with the central domain of CdGAP, but requires
either the CdGAP amino or carboxyl terminus to be pres-
ent, perhaps to stabilize the conformation of the central
domain, as was previously reported for the intersectin-
CdGAP interaction [25]. Importantly, GST-actopaxin
was also able to precipitate the GAP-deficient full-length
CdGAP (R56AN169V) mutant (Figure 5B).
CdGAP was expressed in an in vitro transcription/
translation rabbit reticulocyte system and binding as-
says to GST-actopaxin fusion proteins were performed
in order to evaluate whether the association between
CdGAP and actopaxin was direct. Both full-length (aa
1–372) and amino-terminal (aa 1–95) GST-actopaxin
constructs were found to precipitate the in vitro-synthe-
sized CdGAP (Figure 5C). ILK was also synthesized as
a specificity control, and bound full-length actopaxin
but not the amino-terminal region, consistent with previ-
ous studies (Figure 5C) [33]. Finally, the ability of the en-
dogenous forms of actopaxin and CdGAP to associate
in vivo was confirmed by coimmunoprecipitation from
U2OS cell lysates (Figure 5D). Notably, in U2OS and
HeLa cells, only the short isoform (approximately 90
kDa and identical to the overexpressed isoform used
in this study) of CdGAP is expressed, whereas the longer
isoforms, which are enriched in brain and heart tissue,
are not evident (data not shown) [34].
The Actopaxin-CdGAP Interaction Is Required
for Regulation of Normal Cell Spreading
Because CdGAP was shown to regulate cell spreading
and integrin-dependent morphology (Figures 3 and 4),
the importance of its interaction with actopaxin, a known
regulator of integrin signaling [16, 17], was examined in
this context. RNAi knockdown of endogenous actopaxin
increased spreading, consistent with the increasedlamellipodia formation that has been previously re-
ported (Figures S2A and S2B) [35]. Furthermore, re-
duced levels of actopaxin expression reversed the de-
creased spreading seen with overexpression of
CdGAP, and they did not further enhance the increased
spreading seen with overexpressed GAP-deficient
CdGAP at 30 min after adhesion (Figure S2B). Overall,
these results are consistent with a requirement for acto-
paxin binding in CdGAP effects on integrin-based cell
spreading and further suggest that the increase in
spreading observed after actopaxin knockdown is at
least in part due to disruption of CdGAP signaling.
We next constructed an actopaxin mutant that was
unable to bind CdGAP in order to more specifically
test a role for this interaction in adhesion-dependent
processes. GST fusion proteins consisting of full-length
actopaxin with deletions in aa 1–95 were generated to
further define the CdGAP binding site. A full-length acto-
paxin construct lacking aa 21–25 (actopaxin D21–25)
failed to bind CdGAP, but retained normal binding to
ILK (Figure 6A). Furthermore, an Xpress-actopaxin
D21–25 construct was unable to precipitate Myc-
CdGAP when coexpressed in U2OS cells, but still bound
ILK as effectively as the wild-type protein (Figure 6B).
The Xpress-actopaxin D21–25 was then evaluated for
its ability to affect the rate of cell spreading. Expression
of actopaxin D21–25 in U2OS cells significantly in-
creased spreading at 15 and 30 min after adhesion to
collagen (Figure 6C), whereas wild-type actopaxin was
without significant effect, as previously reported (Fig-
ure 6C) [17]. The increased spreading in cells expressing
actopaxin D21–25 is consistent with perturbation of en-
dogenous CdGAP signaling.
For determining whether CdGAP requires an interac-
tion with actopaxin to exert its inhibitory effect on cell
CdGAP-Actopaxin Interaction in Integrin Signaling
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(A) U2OS cells transfected with Myc-CdGAP were lysed and subjected to binding assays with GST, GST-actopaxin, or GST-actopaxin D21–25.
GST-actopaxin lacking amino acids 21–25 fails to associate with CdGAP but retains normal binding to ILK, and a-actinin served as a negative
control.
(B) U2OS cells were cotransfected with Myc-CdGAP and either Xpress-actopaxin or Xpress-actopaxin D21–25 followed by Omni-probe immu-
noprecipitations of the Xpress-tagged proteins. Xpress-actopaxin D21–25 was unable to bind CdGAP, but retains its association with ILK.
(C) U2OS cells transfected with the indicated constructs were processed to evaluate their effects on cell spreading. Expression of actopaxin
D21–25 significantly increases spreading at 15 and 30 min after adhesion, p < 0.05, as indicated by asterisks. Error bars represent the SEM.
(D) Transfected U2OS cells were spread for 30 min on 10 mg/ml collagen, followed by area quantification. The coexpression of actopaxin D21–25
with CdGAP significantly reverses the inhibited spreading seen in cells overexpressing CdGAP alone, whereas the Xpress actopaxin S4/8D con-
struct does not. All conditions are significantly different than GFP control cells, p < 0.05. Error bars represent the SEM.spreading, actopaxin constructs were coexpressed with
CdGAP, and the transfected cells were allowed to re-
spread on collagen. Coexpression of actopaxin D21–
25 with CdGAP significantly reversed the impaired
spreading that resulted from overexpression of CdGAP
alone (Figure 6D). In contrast, a phospho-mimetic S4/
8D actopaxin mutant that has previously been shown
to promote cell spreading [17], and which binds CdGAP
as effectively as wild-type actopaxin (data not shown),
failed to rescue the CdGAP inhibition of spreading,
thus reinforcing the specificity of the rescue seen with
actopaxin D21–25 (Figure 6D). These results indicate
a specific requirement for actopaxin binding in CdGAP
signaling, whereas the failure of the actopaxin phos-
pho-mimetic S4/8D mutant to revert the reduced
spreading caused by CdGAP overexpression is consis-
tent with the previously reported role for actopaxin
phosphorylation in facilitating the localized function of
Rac effectors [17].
A role for actopaxin in regulation of adhesion-depen-
dent CdGAP signaling was most likely due to either reg-
ulation of CdGAP’s enzymatic activity or focal-adhesiontargeting. An evaluation of GAP activity during spread-
ing was performed with cells that had been transfected
with the GAP and control vector, wild-type actopaxin, or
actopaxin D21–25. CdGAP’s activation during spread-
ing was equivalent under each condition, indicating
that actopaxin binding does not control activity of
CdGAP (data not shown). Similarly, the inclusion of acto-
paxin fusion protein in CdGAP in vitro GAP activity as-
says indicated that the interaction between these pro-
teins does not directly affect the GAP activity of
CdGAP (data not shown). For evaluating the possibility
that actopaxin regulates CdGAP localization to focal ad-
hesions, cytoskeletal fractionation experiments were
performed with asynchronously growing cells versus
cells plated on collagen for 1 hr to determine the amount
of CdGAP localized in the cytoskeletal/focal-adhesion
fraction [36]. In cells expressing Myc-tagged CdGAP
and either empty vector (EV) or wild-type actopaxin,
there was an increase in the amount of CdGAP in the cy-
toskeletal fraction at 60 min after adhesion as opposed
to cells growing asynchronously in culture (Figure 7A).
This increased targeting to the cytoskeleton was lost
Current Biology
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(A) U2OS cells were cotransfected with Myc-CdGAP and empty vector (EV), Xpress-actopaxin wild-type (WT), or Xpress-actopaxin D21–25. Cy-
toskeletal fractionation was performed from cells either growing asynchronously or spread on collagen for 1 hr. The levels of CdGAP are shown
to increase in the cytoskeletal fraction during spreading. However, this increase is lost in cells expressing the actopaxinD21–25 mutant unable to
bind CdGAP.
(B) U2OS cells were cotransfected with GFP-CdGAP, DsRed-paxillin, and either wild-type actopaxin or actopaxin D21–25 and then spread on
collagen for 1 hr. CdGAP localization to focal adhesions was then quantified as detailed in Experimental Procedures. The images shown are rep-
resentative of CdGAP that is either localized or not localized to focal adhesions. The numbers represent percentage of cells exhibiting these
localizations under each condition.
(C) CdGAP overexpression inhibits random motility in transiently transfected U2OS cells. Expression of actopaxin D21–25 reverses the de-
creased motility observed in cells overexpressing CdGAP. Conversely, the actopaxin S4/8D construct causes increased random motility, but
does not increase motility in CdGAP overexpressors. * indicates a significant difference from GFP control cells, p < 0.01. ** indicates that
Xpress-actopaxin D21–25 significantly rescues CdGAP motility defect, while still being significantly below the GFP control cells, p < 0.01. Error
bars represent the standard deviation.when the actopaxin D21–25 mutant was coexpressed
with CdGAP (Figure 7A). In agreement with this result,
expression of actopaxin D21–25 significantly disrupted
the focal-adhesion localization of CdGAP in spreading
cells as quantified by TIRF microscopy (Figure 7B).
These results indicate that expression of an actopaxin
mutant (D21–25) that can target to focal adhesions
(data not shown), but that lacks the capacity to bindCdGAP, diminishes the ability of overexpressed CdGAP
to regulate cell morphology through inhibition of
CdGAP’s recruitment to, or stabilization in, the focal ad-
hesion/cytoskeletal fraction. Further, the inability of ac-
topaxin D21–25 to affect the adhesion-dependent GAP
activity of CdGAP indicates that activation of this GAP
may occur before its targeting to adhesion sites. Alter-
natively, the results presented herein may indicate that
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sion sites with the GAP’s localization being only tran-
sient when its association with actopaxin is disrupted.
This scenario would allow for CdGAP to become acti-
vated during adhesion as a result of its focal-adhesion
localization. A mutant of CdGAP unable to bind acto-
paxin would have to be developed to definitively test
this possibility.
CdGAP Mediates Random Motility
Our results demonstrate that overexpression of CdGAP
inhibits the formation of lamellipodial extensions occur-
ring during cell spreading and polarization. Because the
morphologic events that a cell undergoes during
spreading closely mimic those that occur at the leading
edge of migrating cells [26], we evaluated CdGAP’s abil-
ity to modulate motility by using Modified Boyden cham-
ber assays. Interestingly, CdGAP was found to inhibit
random motility (Figure 7C). Furthermore, expression
of actopaxin D21–25 marginally increased the percent-
age of migrating cells, whereas wild-type actopaxin
was without effect, thereby suggesting a role for acto-
paxin binding to endogenous CdGAP in regulation of
random motility (Figure 7C). This was confirmed by co-
expression of actopaxin D21–25 with CdGAP, a condi-
tion that alleviated the decreased motility observed
with overexpression of the GAP alone (Figure 7C). In
contrast, and as observed with spreading experiments,
the S4/8D actopaxin mutant, which increased random
motility when expressed alone, was unable to revert
the CdGAP phenotype (Figure 7C).
The precise temporal and spatial regulation of the Rho
family of small GTPases plays a critical role in controlling
the cytoskeletal and adhesion changes that are neces-
sary for productive cell migration [6]. For instance, it is
well established that activation of Cdc42 and Rac at
the front of the cell coordinates filopodia and lamellipo-
dia extension, whereas activation of Rho is necessary
for the generation of contractile forces and tail retraction
[6]. In the current study, CdGAP is identified as an impor-
tant negative regulator of integrin-mediated Rac activity.
We show that CdGAP is recruited to focal adhesions,
and consistent with this localization, its GAP activity is
stimulated toward the later stages of integrin-depen-
dent spreading. This time course of CdGAP activation
is in agreement with a role for this protein in reducing
the level of integrin-stimulated Rac activity as the cell
transitions from a spreading to a more polarized motile
phenotype [30].
Importantly, herein we identify the focal-adhesion
protein actopaxin as a direct binding partner for CdGAP
and show that expression of an actopaxin mutant lack-
ing the CdGAP binding site prevents CdGAP-dependent
inhibition of cell spreading and cell migration. These ob-
servations, in addition to the ability of the GAP-dead mu-
tant to induce cell spreading and the formation of multi-
ple lamellipodia while having little effect on global Rac
activity, emphasizes the importance of subcellular com-
partmentalization in facilitating CdGAP function. Inter-
estingly, we have also observed that actopaxin binds
to the PIX family of Rac/Cdc42 GEFs (unpublished ob-
servation, D.P.L., D.M. Clarke, S.E. Hetey, and C.E.T.),
as is the case with affixin, another member of the acto-
paxin/parvin family [18]. This interaction possiblycontributes to the ability of PIX to stimulate cell spread-
ing [37] and cell polarization [38], and may also explain
how actopaxin phosphorylation promotes lamellipodia
formation and cell migration [17]. Whether actopaxin
functions primarily to control the subcellular localization
of CdGAP and PIX, or is also involved directly or indi-
rectly in regulating their enzymatic activity, remains to
be fully determined. Regardless, actopaxin interacts
with both positive and negative regulators of Rac and
Cdc42 signaling, a role shared by another actopaxin
binding partner, paxillin. This focal-adhesion scaffold
protein binds various GEFs and GAPs, including PKL
(an Arf GAP that negatively regulates Rac signaling),
p190RhoGAP, and PIX, and has also been implicated
in the spatial and temporal control of Rho GTPase sig-
naling [12]. A module composed of both actopaxin and
paxillin may constitute a multifunctional hub for the reg-
ulation of p21 GTPase signaling at the plasma mem-
brane, a hub that serves to fine-tune the cell’s response
to external stimuli. This signaling nexus may not only be
important in the control of adhesion signaling in single
motile cells as demonstrated in this report, but could
also constitute an important center of integrin-cytoskel-
eton regulation in muscle tissues. In that context, acto-
paxin has previously been shown to perform an evolu-
tionarily conserved structural role via interactions with
integrin-linked kinase and PINCH [39–41]. Our recent
findings suggest that it may additionally function in the
control of Rho GTPase signaling associated with the
cytoskeleton remodeling that occurs during muscle
contraction [42–44].
Conclusions
The specific GAPs and GEFs that spatially and tempo-
rally control Cdc42 and Rac activity during integrin-me-
diated cell spreading and motility are still poorly defined.
We have identified the Cdc42/Rac GAP CdGAP as an
important negative regulator of adhesion-dependent
signaling and demonstrate that the effects of CdGAP
are dependent upon its direct association with the fo-
cal-adhesion scaffolding protein actopaxin.
Experimental Procedures
Antibodies and Materials
Rabbit polyclonal antibodies to GFP were purchased from Molecu-
lar Probes and Santa Cruz Biotechnologies. Polyclonal antibody to
actopaxin and monoclonal antibody to a-actinin were obtained
from Sigma-Aldrich. Monoclonal antibodies to paxillin, ILK, and
Rac were obtained from BD Transduction laboratories. The Omni-
probe polyclonal antibody was purchased from Santa Cruz Biotech-
nologies. Polyclonal antibody against the CdGAP proline-rich
domain was as previously described [34]. The 9E10 anti-Myc mono-
clonal antibody developed by J.M. Bishop was obtained from the
Developmental Studies Hybridoma Bank developed under the aus-
pices of the NICHD and maintained by The University of Iowa, De-
partment of Biological Sciences (Iowa City, Iowa 52242). Purified
collagen type 1 was purchased from Cohesion.
Plasmids
Xpress-actopaxin D21–25 and GFP-CdGAP R56AN169V constructs
were generated by QuickChange mutagenesis (Stratagene) and se-
quenced in their entirety at the SUNY Upstate DNA Core Facility. Ac-
topaxin and CdGAP truncation constructs were as previously de-
scribed or generated by PCR reactions [16, 17, 25, 45]. GST-PBD
and GST-Rac1 were provided by Richard Cerione (Cornell Univer-
sity, Ithaca, New York). Rac V12 was provided by Mark Symons
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1384(Institute for Medical Research at North Shore-LIJ, Manhasset, New
York). Paxillin-DsRed was provided by Rick Horwitz (University of
Virginia, Charlottesville, Virginia), and RFP-actin was provided by
Klemens Rottner (German Research Centre for Biotechnology,
Braunschweig, Germany).
Cell Spreading, Immunofluorescence, and Morphological
Analysis
Cells were placed in suspension and spread on collagen for times as
indicated and areas quantified as previously described [17, 46].
Standard epifluorescent microscopy imaging was performed with
a Zeiss Axioskop 2 Plus microscope equipped with a SPOT RT slider
camera (Diagnostic Instruments). TIRF microscopy was performed
on a NIKON Eclipse TE-2000 U inverted microscope equipped with
a 603 TIRF objective (CFI Plan/Apo TIRF 603/1.45; Nikon) and
fiber-optic-coupled laser illumination. Cells were cultivated on colla-
gen-coated 35 mm glass-bottomed dishes (MatTek corporation,
Ashland, Massachusetts) and kept at 37ºC in a heating chamber
(model TC-202A, Harvard Apparatus, Holliston, Massachusetts).
Fluorescence was excited either by an argon ion laser (488 nm) or
a HeNe laser (543 nm) and passed through emisson filters optimized
for GFP or TRITC (Chroma Technology, Rockingham, Vermont). Im-
ages were acquired with a cooled CCD camera (Hamamatsu Orca II,
ERG) and processed with SimplePCI software. For evaluation of
actopaxin-dependant CdGAP localization to focal adhesions, TIRF
images were taken of spreading cells that had been cotransfected
with DsRed-paxillin and GFP-CdGAP. CdGAP was considered local-
ized to focal adhesions if it displayed localization to paxillin contain-
ing structures and its pixel intensity at adhesions was at least 2.5
times that of the nonlocalized pool’s pixel intensity.
Cytoskeletal Fractionation
Fractionation of soluble and cytoskeletal fractions was performed
essentially as previously described [36]. Asynchronously growing
cells or cells adherent to 10 mg/ml collagen for 60 min were lysed
in cytoskeletal stabilization buffer (25 mM PIPES, pH 7.2, 0.3 M Su-
crose, 0.5% Triton X-100, 100 mM KCl, 1mM CaCl2, 2.5 mM MgCl2,
200 mM Na3VO4, 2 mM NaF, 10 mg/ml leupeptin, 1 mM PMSF) for
3 min on ice. The supernatant was collected and constituted the
soluble fraction. The residual cellular components constituted the
cytoskeletal component.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures
and two figures and are available with this article online at: http://
www.current-biology.com/cgi/content/full/16/14/1375/DC1/.
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